Swissfirst Bank AG
3
19M
2
1
0.33
1
- Areas of investment
Summary
The main office of represented Corporate Investor is situated in the Zu00fcrich. The company was established in Europe in Switzerland.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Biotechnology, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Pelikan Technologies.
Opposing the other organizations, this Swissfirst Bank AG works on 4 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2006.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Swissfirst Bank AG, startups are often financed by Mannheim Holdings, Heidelberg Innovation, HBM Healthcare Investments AG. The meaningful sponsors for the fund in investment in the same round are HBM Healthcare Investments AG, Wellington Partners, Nexus Medical Partners. In the next rounds fund is usually obtained by HBM Healthcare Investments AG, Gilde Healthcare, Wellington Partners.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Exits
- 1
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Medical Device (2)
- Health Care (2)
- Health Diagnostics (1)
- Medical (1)
- Investments by region
-
- United States (2)
- Germany (1)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 76M
- Group Appearance index
- 0.67
- Avg. company exit year
- 12
- Avg. multiplicator
- 1.56
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| MTM Laboratories | 10 Oct 2006 | Biotechnology, Health Diagnostics, Medical | Late Stage Venture | 28M | Germany, Baden-Württemberg, Heidelberg |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.